Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.63872 | 26 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.60864 | 27 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.61526 | 27 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.52776 | 25 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.56424 | 27 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.64093 | 25 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.79728 | 33 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.62339 | 28 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.57701 | 26 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.66635 | 30 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.58231 | 26 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.567 | 26 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.6038 | 26 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.59897 | 26 |